drug for the treatment of coronavirus “Levelmap” of Biocad should arrive in the Russian hospital in about three weeks. It is reported by RIA “Novosti” with reference to press service company.
— Production will begin after certification in the near future, then coming to the hospital, after three weeks, specified in the the press service, noting that the drug would be administered by doctors of medical institutions.
“Levelmap” is indicated for patients with severe disease. Its action is due to cytokine storm and inflammatory reaction of the human immune system, the infected CoViD-19. Thus it is contraindicated in children and adolescents under 18 years, pregnant and lactating women and patients with severe hepatic insufficiency and bacterial infections in the acute phase, including tuberculosis.
Recall that the first Russian drug from the coronavirus was approved by the Ministry of health in late may. It’s called “Aviewer” and will be delivered to the hospital next week.
